AMA Delegates Dismayed With Prevention Task Force
This article was originally published in The Gray Sheet
Executive Summary
A new American Medical Association policy expresses “concern” over the U.S. Preventive Services Task Force's recommendations on mammography and PSA screening. In the future, the task force should obtain input from disease specialists, it says. Some members of Congress agree.
You may also be interested in...
PSA Prostate Cancer Screening Does More Harm Than Good, USPSTF Concludes
The final recommendations are a major shift in policy for the commonly performed blood test, and one certain to face ongoing controversy.
Task Force Mammography Guidelines Present Challenges And Opportunities
Mammography coverage policies among public and private payers are not likely to be restricted, at least in the near term, by the U.S. Preventive Services Task Force's new breast cancer screening guidelines, but prospects for longer-term adjustments remain
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.